Islet cell transplantation for the treatment of type 1 diabetes

Record ID 32005000038
Authors' objectives:

Islet cell transplantation is performed in patients with type 1 (insulin-dependent) diabetes mellitus, with the goals of eliminating the need for exogenous insulin and improving glucose control, thereby preventing or reversing secondary diabetic complications, such as retinopathy, neuropathy, nephropathy, and vasculopathy.

Authors' methods: Review
Project Status: Completed
URL for project:
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Diabetes Mellitus, Type 1
  • Islets of Langerhans Transplantation
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
Contact Email:
Copyright: HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.